Last update:

   15-Jul-2022
 

Arch Hellen Med, 39(Supplement 1), 2022, 9-23

Blood and Beyond Greece
Priorities and actions for ensuring availability of blood for transfusion dependent patients

K. Souliotis,1,2 C. Golna,2,3 A. Kattamis,4 K. Stamoulis,5 E. Grouzi,6 V. Myrilla,7,8 G. Peppes,9 V. Dimos,10 P. Stratigopoulou11
1Department of Social and Education Policy, School of Social and Political Sciences, Corinth, Greece,
2Health Policy Institute, Athens, Greece,
3Innowth Ltd, Larnaca, Cyprus,
4Thalassemia Unit, First Department of Pediatrics, National and Kapodistrian University of Athens, Greece,
5 Hellenic National Blood Transfusion Centre, Acharnes, Greece,
6Transfusion Service and Clinical Haemostasis, "St Savvas" Oncology Hospital, Athens, Greece,
7Laboratory Medicine Department of Haematology, "Agia Sofia" Children's Hospital, Athens, Greece,
8Panhellenic Association of Thalassaemia and Sickle Cell Disease Patients (PASPAMA), Athens, Greece,
9Greek Patients' Association, Athens, Greece,
10Greek Thalassaemia Association (ESTHA), Thessaloniki, Greece,
11"Laiko" General Hospital, Athens, Greece

Effective patient blood management constitutes a persistent challenge for healthcare systems and public health across Europe. Especially in Greece, a country with a traditionally high prevalence of β-thalassemia and other haemoglobinopathies, it is critical to ensure availability of blood to cover the needs of systematically transfused patients. A recent prospective study highlighted a potential gap in meeting future needs in red blood cell units in Greece for transfusion-dependent patients with β-thalassemia over the next 15 years. The present study, which is part of the pan-European initiative "Blood & Beyond", discusses current challenges and proposes structured activities with measurable outcomes to increase and sustain blood supply and optimize blood demand.

Key words: Blood donation, β-Thalassemia, Patient blood management, Transfusion.


© Archives of Hellenic Medicine